Synergy Pharmaceuticals Short Interest
Short interest at Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) totaled nearly 62.53 million shares at the conclusion of February, after a pullback of more than 3.6 million from the prior settlement date. Still, that represented a whopping 59.1 % of the total float, even if it was the fewest shares short since last July. The days to cover rose from around 11 to more than 16 during the latest period as the average daily volume shrank again.
This biopharmaceutical company is focused on treatments for constipation and irritable bowel syndrome. Short sellers watched the stock fall almost 13% in those two weeks, only to roar back more than 22% after the settlement date. The most recent closing share price was $2.17, which is more than 11% lower year to date. The shares have changed hands between $1.68 and $5.43 apiece in the past year.
Successful Trading is the art of minimizing long term risk and maximizing capital allocation.
